Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5952-5960

  Marsili, Alessandro ^a   Ramadan, Waile ^c   Harney, John W ^a   Mulcahey, Michelle ^b   Castroneves, Luciana Audi ^b   Goemann, Iuri Martin ^d   Wajner, Simone Magagnin ^d   Huang, Stephen A ^b   Zavacki, Ann Marie ^a   Maia, Ana Luiza ^d   Dentice, Monica ^e   Salvatore, Domenico ^e   Silva, J Enrique ^c   Larsen, P Reed ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODOTHYRONINE DEIODINASE TYPE 2; MESSENGER RNA; THYROID PEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE; HYPOTHYROIDISM; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; SKELETAL MUSCLE;

ANIMALS; ANIMALS, NEWBORN; ANTITHYROID AGENTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; METHIMAZOLE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; RNA, MESSENGER;

EID: 78649899781     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0631     Document Type: Article

References (41)

1. Lowell BB, Spiegelman BM 2000 Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660
2. Simonides WS, van Hardeveld C 2008 Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 18:205-216
3. Zurlo F, Larson K, Bogardus C, Ravussin E 1990 Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86:1423-1427
4. Silva JE 2006 Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86:435-464
5. Clément K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D 2002 In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 12:281-291
6. Visser WE, Heemstra KA, Swagemakers SM, Ozgur Z, Corssmit EP, Burggraaf J, van Ijcken WF, van der Spek PJ, Smit JW, Visser TJ 2009 Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. J Clin Endocrinol Metab 94:3487-3496
7. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
8. Nguyen TT, Chapa F, DiStefano 3rd JJ 1998 Direct measurement of the contributions of type I and type II 5′-deiodinases to whole body steady state 3,5,3′-triiodothyronine production from thyroxine in the rat. Endocrinology 139:4626-4633
9. 3 in euthyroid humans. J Clin Invest 115:2524-2533
10. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308-3315
11. Croteau W, Davey JC, Galton VA, St. Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405-417
12. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE 2008 Mice lacking the thyroid hormone receptor-α gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. Endocrinology 149:6471-6486
13. Grozovsky R, Ribich S, Rosene ML, Mulcahey MA, Huang SA, Patti ME, Bianco AC, Kim BW 2009 Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. Endocrinology 150:1976-1983
14. Heemstra KA, Soeters MR, Fliers E, Serlie MJ, Burggraaf J, van Doorn MB, van der Klaauw AA, Romijn JA, Smit JW, Corssmit EP, Visser TJ 2009 Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. J Clin Endocrinol Metab 94:2144-2150
15. Mebis L, Langouche L, Visser TJ, Van den Berghe G 2007 The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab 92:3330-3333
16. Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, Alvarez-Escudero J, Lado-Abeal J 2008 Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxf) 68:821-827
17. Kwakkel J, van Beeren H, Ackermans M, Platvoet-Ter Schiphorst M, Fliers E, Wiersinga W, Boelen A 2009 Skeletal muscle deiodinase type 2 regulation during illness in mice. J Endocrinol 203:263-270
18. Steinsapir J, Bianco AC, Buettner C, Harney J, Larsen PR 2000 Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Endocrinology 141:1127-1135
19. Christoffolete MA, Linardi CC, de Jesus L, Ebina KN, Carvalho SD, Ribeiro MO, Rabelo R, Curcio C, Martins L, Kimura ET, Bianco AC 2004 Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 53:577-584
20. 4. Mol Endocrinol 15:2137-2148
21. Pachucki J, Hopkins J, Peeters R, Tu H, Carvalho SD, Kaulbach H, Abel ED, Wondisford FE, Ingwall JS, Larsen PR 2001 Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 142:13-20
22. Richard K, Hume R, Kaptein E, Sanders JP, van Toor H, De Herder WW, den Hollander JC, Krenning EP, Visser TJ 1998 Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab 83:2868-2874
23. Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, Harney JW, Cheng SY, Larsen PR, Bianco AC 2005 Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 146:1568-1575
24. Castillo M, Freitas BC, Rosene ML, Drigo RA, Grozovsky R, Maciel RM, Patti ME, Ribeiro MO, Bianco AC 2010 Impaired metabolic effects of a thyroid hormone receptor β-selective agonist in a mouse model of diet-induced obesity. Thyroid 20:545-553
25. Freitas BC, Gereben B, Castillo M, Kalló I, Zeöld A, Egri P, Liposits Z, Zavacki AM, Maciel RM, Jo S, Singru P, Sanchez E, Lechan RM, Bianco AC 2010 Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120:2206-2217
26. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-3211
27. Salvatore D, Low SC, Berry M, Maia AL, Harney JW, Croteau W, St. Germain DL, Larsen PR 1995 Type 3 lodothyronine deiodinase: cloning, in vitro expression, and the functional analysis of the placental selenoenzyme. J Clin Invest 96:2421-2430
28. Hitomi Y, Kizaki T, Watanabe S, Matsumura G, Fujioka Y, Haga S, Izawa T, Taniguchi N, Ohno H 2005 Seven skeletal muscles rich in slow muscle fibers may function to sustain neutral position in the rodent hindlimb. Comp Biochem Physiol B Biochem Mol Biol 140:45-50
29. Ariano MA, Armstrong RB, Edgerton VR 1973 Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 21:51-55
30. Burmeister LA, Pachucki J, St Germain DL 1997 Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138:5231-5237
31. Tseng YL, Latham KR 1984 Iodothyronines: oxidative deiodination by hemoglobin and inhibition of lipid peroxidation. Lipids 19:96-102
32. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478
33. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898-938
34. Zavacki AM, Arrojo E Drigo R, Freitas BC, Chung M, Harney JW, Egri P, Wittmann G, Fekete C, Gereben B, Bianco AC 2009 The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol Cell Biol 29:5339-5347
35. Kwakkel J, Chassande O, van Beeren HC, Fliers E, Wiersinga WM, Boelen A 2010 Thyroid hormone receptor α modulates lipopolysaccharide-induced changes in peripheral thyroid hormone metabolism. Endocrinology 151:1959-1969
36. Ramadan WHS, Marsili A, Larsen P, Silva J Mouse skeletal muscle microsomes have type-2 iodothyronine deiodinase (D2) mRNA and activity. Possible role in hypermetabolism of TR deficient mice. Program of the 80th Annual Meeting of the American Thyroid Association, Palm Beach, FL, 2009, p 177 (Abstract O65)
37. Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ, Van den Berghe G 2005 Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′- triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90:4559-4565
38. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT, Ragg KE, Toma K 2000 Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 48:623-629
39. 4 concentration in red and white skeletal muscle and plasma of euthyroid rats. Acta Endocrinol (Copenh) 90:81-89
40. Silva JE, Larsen PR 1982 Comparison of iodothyronine 5′-deiodinase and other thyroid-hormone-dependent enzyme activities in the cerebral cortex of hypothyroid neonatal rat. Evidence for adaptation to hypothyroidism. J Clin Invest 70:1110-1123
41. Cheron RG, Kaplan MM, Larsen PR 1979 Physiological and pharmacological influences on thyroxine to 3,5,3′-triiodothyronine conversion and nuclear 3,5,3′-triiodothyronine binding in rat anterior pituitary. J Clin Invest 64:1402-1414